Binding of the Promen fluorescent probe to human serum albumin -: A fluorescence spectroscopic study

被引:53
作者
Moreno, F [1 ]
González-Jiménez, J [1 ]
机构
[1] Univ Complutense Madrid, Fac Farm, Dept Quim Fis Farmaceut, Unidad RMN, Madrid 28040, Spain
关键词
Promen; binding sites; HSA; fluorescent probes;
D O I
10.1016/S0009-2797(99)00111-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The binding of Promen (6-propionyl-2-methoxynapthalene) to human serum albumin (HSA) was measured by fluorescence spectroscopy, finding only one class of binding sites on the protein. Hydrophobic interactions play an important role to stabilize the complex. Attempts were made to characterize its binding site using as competitors warfarin, phenylbutazone and diazepam, which bind in a specific site or region on the HSA. Fluorescence polarization measurements and spectrofluorimetric results suggest that diazepam and Promen bind at different but interacting binding sites on the HSA. The changes in the fluorescence emission of the bound Promen in the presence of these drugs, allow to use Promen to detect unspecific interactions with the site II on the HSA. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:237 / 252
页数:16
相关论文
共 27 条
[1]  
CARRUPT PA, 1991, METHOD ENZYMOL, V203, P638
[2]  
Catalan J, 1991, J Fluoresc, V1, P215, DOI 10.1007/BF00865246
[3]   FLUORESCENCE QUENCHING STUDIES ON BINDING FLUORENO-9-SPIRO-OXAZOLIDINEDIONE TO HUMAN SERUM-ALBUMIN [J].
GONZALEZJIMENEZ, J ;
JACQUOTTE, H ;
CAYRE, I .
CHEMICO-BIOLOGICAL INTERACTIONS, 1992, 84 (03) :221-228
[4]   CHLORPHENIRAMINE BINDING TO HUMAN SERUM-ALBUMIN BY FLUORESCENCE QUENCHING MEASUREMENTS [J].
GONZALEZJIMENEZ, J ;
FRUTOS, G ;
CAYRE, I ;
CORTIJO, M .
BIOCHIMIE, 1991, 73 (05) :551-556
[5]   ANALYSIS OF THE BINDING OF CHLORPHENIRAMINE TO HUMAN SERUM-ALBUMIN BY SPECTROSCOPIC TECHNIQUES [J].
GONZALEZJIMENEZ, J .
CHEMICO-BIOLOGICAL INTERACTIONS, 1994, 91 (01) :65-74
[6]  
KANEO Y, 1979, CHEM PHARM BULL, V27, P1335
[7]  
KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17
[8]  
KRAGHHANSEN U, 1990, MOL PHARMACOL, V37, P238
[9]  
KURONO Y, 1992, CHEM PHARM BULL, V40, P2169
[10]  
MAES V, 1982, MOL PHARMACOL, V21, P100